Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS
Home/The Filing Wire/Caris Life Sciences, Inc./ 10-Q

Quarterly Report · 10-Q

Caris Life Sciences, Inc.

CAINASDAQEQUITYCurrent

Quarterly Report

Filed Aug 5, 2026Accepted Aug 5, 2026, 5:00 PM EDTCIK 2019410Accession 0002019410-26-000055
View company →Permanent SEC source ↗
Share

Company context

We are a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer. We develop and commercialize innovative solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Our entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets.

Current securities

CAINASDAQ · EQUITY · Current

Recent company filings

  1. 144 filingSep 22, 2026
  2. 144 filingSep 17, 2026
  3. Regulation FD DisclosureSep 14, 2026
  4. 144 filingSep 4, 2026
  5. 144 filingSep 3, 2026

Registered securities in this filing

CARIS LIFE SCIENCES, INC. · 10-Q · Filed 2026-08-05

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock, $0.001 par value

Symbol
CAI
Exchange
CHX
Classification
COMMON
Status
Current
Filing context

Context: c-3

Dimensions: dei:EntityListingsExchangeAxis

Common Stock, $0.001 par value

Symbol
CAI
Exchange
NASDAQ
Classification
COMMON
Status
Current
Filing context

Context: c-2

Dimensions: dei:EntityListingsExchangeAxis

Accession 000201941026000055 · 2 registered-security cover members

Read the exact SEC filing ↗

As-filed source

Primary evidence
As filedOpen full document ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.